Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 28.05% is 20% below its 5-year average of 34.86%, near the low end of its 5-year range (28.05%–38.35%).
As of the fiscal period ended Saturday, March 28, 2026. 12.13% below its 12-month average of 31.92%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
28.05%
GROSS MARGIN AVG TTM
31.92%
GROSS MARGIN AVG 3Y
33.58%
GROSS MARGIN AVG 5Y
35.60%
GROSS MARGIN AVG 10Y
36.43%
GROSS MARGIN AVG 15Y
36.33%
GROSS MARGIN AVG 20Y
36.44%
CURRENT VS TTM AVG
-12.13%
CURRENT VS 3Y AVG
-16.48%
CURRENT VS 5Y AVG
-21.21%
CURRENT VS 10Y AVG
-23.01%
CURRENT VS 15Y AVG
-22.80%
CURRENT VS 20Y AVG
-23.02%
SECTOR MEDIAN · HEALTHCARE
59.09%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-52.53%
vs the sector median at left
Charles River Laboratories International, Inc.
Market Cap
$11.20B
Gross Margin
28.05%
TTM Avg
31.92%
3Y Avg
33.58%
5Y Avg
35.60%
Market Cap
$11.29B
Gross Margin
64.96%
TTM Avg
65.60%
3Y Avg
66.84%
5Y Avg
66.79%
Market Cap
$10.37B
Gross Margin
17.13%
TTM Avg
18.71%
3Y Avg
19.98%
5Y Avg
20.79%
Market Cap
$12.11B
Gross Margin
68.16%
TTM Avg
69.16%
3Y Avg
69.73%
5Y Avg
70.75%
Market Cap
$10.21B
Gross Margin
13.07%
TTM Avg
12.36%
3Y Avg
12.43%
5Y Avg
12.55%
Market Cap
$10.20B
Gross Margin
90.45%
TTM Avg
90.21%
3Y Avg
89.67%
5Y Avg
89.38%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | $11.20B | 28.05% | 31.92% | 33.58% | 35.60% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 64.96% | 65.60% | 66.84% | 66.79% |
| Insulet Corp. (PODD)vs › | $11.45B | 71.01% | 70.71% | 67.87% | 67.39% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 17.13% | 18.71% | 19.98% | 20.79% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 68.16% | 69.16% | 69.73% | 70.75% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | 13.07% | 12.36% | 12.43% | 12.55% |
| Universal Health Services, Inc. (UHS)vs › | $10.20B | 90.45% | 90.21% | 89.67% | 89.38% |
| Revvity, Inc. (RVTY)vs › | $12.55B | 51.44% | 50.55% | 50.58% | 52.43% |
| Henry Schein, Inc. (HSIC)vs › | $9.77B | 29.69% | 29.43% | 29.32% | 29.12% |
| Baxter International Inc. (BAX)vs › | $13.51B | 30.08% | 33.76% | 35.72% | 36.84% |
Gross Margin
28.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-28 | 28.05% |
| 2025-12-27 | 30.96% |
| 2025-09-27 | 33.72% |
| 2025-06-28 | 34.59% |
| 2025-03-29 | 32.28% |
| 2024-12-31 | 28.35% |
| 2024-09-28 | 34.56% |
| 2024-06-29 | 34.47% |
| 2024-03-30 | 34.09% |
| 2023-12-31 | 35.92% |
| 2023-09-30 | 35.25% |
| 2023-07-01 | 37.64% |
| 2023-04-01 | 36.69% |
| 2022-12-31 | 36.27% |
| 2022-09-24 | 37.43% |
| 2022-06-25 | 36.66% |
| 2022-03-26 | 36.85% |
| 2021-12-31 | 38.35% |
| 2021-09-25 | 37.64% |
| 2021-06-26 | 37.40% |
| 2021-03-27 | 37.39% |
| 2020-12-31 | 37.92% |
| 2020-09-26 | 38.92% |
| 2020-06-27 | 34.02% |
| 2020-03-28 | 35.65% |
| 2019-12-31 | 37.95% |
| 2019-09-28 | 36.85% |
| 2019-06-29 | 36.21% |
| 2019-03-30 | 35.03% |
| 2018-12-31 | 37.64% |
| 2018-09-29 | 36.94% |
| 2018-06-30 | 36.90% |
| 2018-03-31 | 36.74% |
| 2017-12-31 | 35.06% |
| 2017-09-30 | 38.09% |
| 2017-07-01 | 39.50% |
| 2017-04-01 | 38.44% |
| 2016-12-31 | 38.54% |
| 2016-09-24 | 36.71% |
| 2016-06-25 | 39.11% |
| 2016-03-26 | 39.67% |
| 2015-12-31 | 39.73% |
| 2015-09-26 | 39.51% |
| 2015-06-27 | 39.10% |
| 2015-03-28 | 37.35% |
| 2014-12-31 | 36.40% |
| 2014-09-27 | 36.10% |
| 2014-06-28 | 36.82% |
| 2014-03-29 | 36.35% |
| 2013-12-31 | 31.95% |
| 2013-09-28 | 34.21% |
| 2013-06-29 | 35.01% |
| 2013-03-30 | 35.78% |
| 2012-12-31 | 33.76% |
| 2012-09-29 | 33.46% |
| 2012-06-30 | 36.38% |
| 2012-03-31 | 36.44% |
| 2011-12-31 | 34.56% |
| 2011-09-24 | 33.40% |
| 2011-06-25 | 36.88% |
| 2011-03-26 | 35.91% |
| 2010-12-31 | 34.95% |
| 2010-09-25 | 32.78% |
| 2010-06-26 | 34.50% |
| 2010-03-27 | 33.36% |
| 2009-12-31 | 33.90% |
| 2009-09-26 | 35.82% |
| 2009-06-27 | 37.14% |
| 2009-03-28 | 35.89% |
| 2008-12-31 | 35.99% |
| 2008-09-27 | 38.07% |
| 2008-06-28 | 39.19% |
| 2008-03-29 | 38.61% |
| 2007-12-31 | 37.03% |
| 2007-09-29 | 39.46% |
| 2007-06-30 | 39.34% |
| 2007-03-31 | 39.69% |
| 2006-12-31 | 37.44% |
| 2006-09-30 | 38.64% |
| 2006-07-01 | 39.99% |
| 2006-04-01 | 33.66% |
| 2005-12-31 | 36.25% |
| 2005-09-24 | 38.98% |
| 2005-06-25 | 35.85% |
| 2005-03-26 | 38.22% |
| 2004-12-31 | 36.01% |
| 2004-09-25 | 39.42% |
| 2004-06-26 | 41.41% |
| 2004-03-27 | 39.87% |
| 2003-12-31 | 38.20% |
| 2003-09-27 | 37.36% |
| 2003-06-28 | 38.60% |
| 2003-03-29 | 38.11% |
| 2002-12-31 | 37.18% |
| 2002-09-28 | 37.83% |
| 2002-06-29 | 38.39% |
